BIO logo

Bio-Rad Laboratories, Inc. (BIO) Cash From Investing

Annual CFI:

-$160.20M-$180.41M(-892.76%)
December 31, 2024

Summary

  • As of today, BIO annual cash from investing is -$160.20 million, with the most recent change of -$180.41 million (-892.76%) on December 31, 2024.
  • During the last 3 years, BIO annual cash from investing has risen by +$637.18 million (+79.91%).
  • BIO annual cash from investing is now -892.76% below its all-time high of $20.21 million, reached on December 31, 2023.

Performance

BIO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

Quarterly CFI:

-$115.40M-$118.30M(-4079.31%)
June 30, 2025

Summary

  • As of today, BIO quarterly cash from investing is -$115.40 million, with the most recent change of -$118.30 million (-4079.31%) on June 30, 2025.
  • Over the past year, BIO quarterly cash from investing has dropped by -$84.47 million (-273.14%).
  • BIO quarterly cash from investing is now -164.12% below its all-time high of $179.99 million, reached on September 30, 2013.

Performance

BIO Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

TTM CFI:

-$198.68M-$84.47M(-73.96%)
June 30, 2025

Summary

  • As of today, BIO TTM cash from investing is -$198.68 million, with the most recent change of -$84.47 million (-73.96%) on June 30, 2025.
  • Over the past year, BIO TTM cash from investing has dropped by -$187.36 million (-1654.66%).
  • BIO TTM cash from investing is now -379.84% below its all-time high of $71.00 million, reached on March 31, 2014.

Performance

BIO TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIOcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BIO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-892.8%-273.1%-1654.7%
3Y3 Years+79.9%+20.1%+88.4%
5Y5 Years+23.3%-30.3%-178.5%

BIO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-892.8%+86.7%-259.8%at low-517.5%+88.4%
5Y5-Year-892.8%+86.7%-227.0%+87.4%-517.5%+88.4%
All-TimeAll-Time-892.8%+86.7%-164.1%+87.4%-379.8%+88.4%

BIO Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$115.40M(-4079.3%)
-$198.68M(-74.0%)
Mar 2025
-
$2.90M(+109.5%)
-$114.21M(+28.7%)
Dec 2024
-$160.20M(-892.8%)
-$30.54M(+45.1%)
-$160.20M(-178.8%)
Sep 2024
-
-$55.64M(-79.9%)
-$57.46M(-407.5%)
Jun 2024
-
-$30.93M(+28.2%)
-$11.32M(-123.8%)
Mar 2024
-
-$43.09M(-159.7%)
$47.59M(+135.5%)
Dec 2023
$20.21M(+101.7%)
$72.20M(+860.0%)
$20.21M(+118.3%)
Sep 2023
-
-$9.50M(-133.9%)
-$110.54M(+41.7%)
Jun 2023
-
$27.98M(+139.7%)
-$189.46M(+47.7%)
Mar 2023
-
-$70.47M(-20.4%)
-$361.93M(+70.0%)
Dec 2022
-$1.21B(-51.4%)
-$58.55M(+33.8%)
-$1.21B(+29.6%)
Sep 2022
-
-$88.42M(+38.8%)
-$1.72B(-0.4%)
Jun 2022
-
-$144.48M(+84.2%)
-$1.71B(-2.7%)
Mar 2022
-
-$916.14M(-61.5%)
-$1.67B(-108.8%)
Dec 2021
-$797.38M(-1223.5%)
-$567.43M(-597.5%)
-$797.38M(-184.7%)
Sep 2021
-
-$81.35M(+18.9%)
-$280.06M(-159.7%)
Jun 2021
-
-$100.28M(-107.5%)
-$107.86M(-12.2%)
Mar 2021
-
-$48.33M(+3.6%)
-$96.16M(-59.6%)
Dec 2020
-$60.25M(+71.2%)
-$50.11M(-155.2%)
-$60.25M(+15.5%)
Sep 2020
-
$90.85M(+202.6%)
-$71.34M(+73.8%)
Jun 2020
-
-$88.57M(-613.0%)
-$272.10M(-37.0%)
Mar 2020
-
-$12.42M(+79.7%)
-$198.60M(+4.9%)
Dec 2019
-$208.89M(-11.7%)
-$61.20M(+44.3%)
-$208.89M(-3.2%)
Sep 2019
-
-$109.91M(-629.3%)
-$202.50M(-65.8%)
Jun 2019
-
-$15.07M(+33.6%)
-$122.10M(+36.0%)
Mar 2019
-
-$22.71M(+58.6%)
-$190.88M(-2.1%)
Dec 2018
-$186.98M(-6.5%)
-$54.81M(-85.7%)
-$186.98M(-28.7%)
Sep 2018
-
-$29.51M(+64.8%)
-$145.25M(-11.3%)
Jun 2018
-
-$83.84M(-345.6%)
-$130.56M(-55.4%)
Mar 2018
-
-$18.82M(-43.8%)
-$84.00M(+52.2%)
Dec 2017
-$175.57M(+17.9%)
-$13.08M(+11.7%)
-$175.57M(+17.3%)
Sep 2017
-
-$14.81M(+60.3%)
-$212.26M(+15.4%)
Jun 2017
-
-$37.28M(+66.2%)
-$250.88M(+8.1%)
Mar 2017
-
-$110.39M(-121.8%)
-$273.06M(-27.9%)
Dec 2016
-$213.88M(-31.5%)
-$49.77M(+6.8%)
-$213.53M(+12.2%)
Sep 2016
-
-$53.43M(+10.2%)
-$243.32M(-12.1%)
Jun 2016
-
-$59.47M(-16.9%)
-$217.13M(-17.0%)
Mar 2016
-
-$50.86M(+36.1%)
-$185.53M(-14.1%)
Dec 2015
-$162.66M(+14.6%)
-$79.57M(-192.2%)
-$162.66M(-22.7%)
Sep 2015
-
-$27.23M(+2.3%)
-$132.53M(+8.2%)
Jun 2015
-
-$27.86M(+0.5%)
-$144.43M(+19.6%)
Mar 2015
-
-$27.99M(+43.4%)
-$179.58M(+5.7%)
Dec 2014
-$190.51M(-3414.3%)
-$49.44M(-26.4%)
-$190.51M(-3.9%)
Sep 2014
-
-$39.13M(+37.9%)
-$183.40M(-613.5%)
Jun 2014
-
-$63.02M(-61.9%)
$35.72M(-49.7%)
Mar 2014
-
-$38.92M(+8.1%)
$71.00M(+1409.7%)
Dec 2013
-$5.42M(+98.7%)
-$42.34M(-123.5%)
-$5.42M(+84.6%)
Sep 2013
-
$179.99M(+749.0%)
-$35.13M(+89.0%)
Jun 2013
-
-$27.73M(+76.0%)
-$319.04M(+27.8%)
Mar 2013
-
-$115.34M(-60.1%)
-$441.86M(-7.0%)
Dec 2012
-$412.80M(-7.7%)
-$72.04M(+30.7%)
-$412.80M(+19.1%)
Sep 2012
-
-$103.93M(+31.0%)
-$510.29M(-10.4%)
Jun 2012
-
-$150.55M(-74.5%)
-$462.18M(-17.8%)
Mar 2012
-
-$86.28M(+49.1%)
-$392.40M(-2.3%)
Dec 2011
-$383.41M(-77.1%)
-$169.52M(-203.7%)
-$383.41M(-44.1%)
Sep 2011
-
-$55.81M(+30.9%)
-$265.99M(+2.0%)
Jun 2011
-
-$80.78M(-4.5%)
-$271.44M(-25.2%)
Mar 2011
-
-$77.29M(-48.3%)
-$216.79M(-0.1%)
Dec 2010
-$216.51M(-23.1%)
-$52.10M(+15.0%)
-$216.51M(-15.8%)
Sep 2010
-
-$61.26M(-134.4%)
-$187.00M(+10.2%)
Jun 2010
-
-$26.14M(+66.1%)
-$208.33M(+13.3%)
Mar 2010
-
-$77.01M(-240.9%)
-$240.25M(-36.5%)
Dec 2009
-$175.95M(-20.4%)
-$22.59M(+72.6%)
-$175.95M(+19.1%)
Sep 2009
-
-$82.59M(-42.3%)
-$217.60M(-32.1%)
Jun 2009
-
-$58.05M(-356.5%)
-$164.72M(-33.0%)
Mar 2009
-
-$12.72M(+80.2%)
-$123.86M(+15.2%)
Dec 2008
-$146.11M(+42.6%)
-$64.24M(-116.2%)
-$146.11M(+69.3%)
Sep 2008
-
-$29.71M(-72.9%)
-$476.36M(-76.0%)
Jun 2008
-
-$17.19M(+50.8%)
-$270.60M(+10.2%)
Mar 2008
-
-$34.96M(+91.1%)
-$301.25M(-18.4%)
Dec 2007
-$254.43M(-22.5%)
-$394.49M(-324.1%)
-$254.43M(-483.2%)
Sep 2007
-
$176.04M(+468.0%)
$66.40M(+138.6%)
Jun 2007
-
-$47.84M(-503.4%)
-$171.93M(+15.8%)
Mar 2007
-
$11.86M(+116.1%)
-$204.08M(+1.7%)
Dec 2006
-$207.70M
-$73.66M(-18.3%)
-$207.70M(-64.9%)
Sep 2006
-
-$62.29M(+22.1%)
-$125.92M(-24.8%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$79.99M(-1071.1%)
-$100.92M(-9.9%)
Mar 2006
-
$8.24M(+1.4%)
-$91.82M(-1387.7%)
Dec 2005
-$6.17M(+96.7%)
$8.12M(+121.8%)
-$6.17M(+94.4%)
Sep 2005
-
-$37.29M(+47.4%)
-$110.78M(+6.0%)
Jun 2005
-
-$70.89M(-175.5%)
-$117.89M(-104.1%)
Mar 2005
-
$93.89M(+197.3%)
-$57.76M(+69.0%)
Dec 2004
-$186.32M(-74.1%)
-$96.49M(-117.3%)
-$186.32M(-56.8%)
Sep 2004
-
-$44.39M(-312.4%)
-$118.81M(-5.9%)
Jun 2004
-
-$10.77M(+68.9%)
-$112.15M(+7.3%)
Mar 2004
-
-$34.67M(-19.6%)
-$120.94M(-13.0%)
Dec 2003
-$106.99M(-96.3%)
-$28.98M(+23.2%)
-$106.99M(-17.9%)
Sep 2003
-
-$37.73M(-93.0%)
-$90.74M(-37.5%)
Jun 2003
-
-$19.55M(+5.7%)
-$65.98M(+1.0%)
Mar 2003
-
-$20.73M(-62.9%)
-$66.64M(-22.3%)
Dec 2002
-$54.50M(-14.7%)
-$12.73M(+1.9%)
-$54.50M(-2.9%)
Sep 2002
-
-$12.97M(+35.8%)
-$52.95M(+8.6%)
Jun 2002
-
-$20.21M(-135.5%)
-$57.92M(-20.9%)
Mar 2002
-
-$8.58M(+23.2%)
-$47.92M(-0.9%)
Dec 2001
-$47.50M(-611.0%)
-$11.18M(+37.7%)
-$47.50M(-31.5%)
Sep 2001
-
-$17.94M(-75.6%)
-$36.13M(-937.9%)
Jun 2001
-
-$10.22M(-25.2%)
$4.31M(-38.6%)
Mar 2001
-
-$8.16M(-4440.4%)
$7.02M(-24.5%)
Dec 2000
$9.30M(+104.2%)
$188.00K(-99.2%)
$9.30M(+104.6%)
Sep 2000
-
$22.50M(+399.6%)
-$202.07M(+11.2%)
Jun 2000
-
-$7.51M(-27.6%)
-$227.61M(-0.7%)
Mar 2000
-
-$5.88M(+97.2%)
-$225.99M(-1.2%)
Dec 1999
-$223.32M(-784.3%)
-$211.18M(-6835.2%)
-$223.32M(-1083.4%)
Sep 1999
-
-$3.04M(+48.3%)
-$18.87M(-0.4%)
Jun 1999
-
-$5.88M(-83.2%)
-$18.79M(+17.8%)
Mar 1999
-
-$3.21M(+52.3%)
-$22.85M(+9.5%)
Dec 1998
-$25.25M(+54.8%)
-$6.73M(-126.9%)
-$25.25M(+55.3%)
Sep 1998
-
-$2.97M(+70.2%)
-$56.51M(+10.5%)
Jun 1998
-
-$9.94M(-77.0%)
-$63.17M(-9.9%)
Mar 1998
-
-$5.62M(+85.2%)
-$57.46M(-2.7%)
Dec 1997
-$55.92M(-276.8%)
-$37.98M(-294.5%)
-$55.92M(-130.3%)
Sep 1997
-
-$9.63M(-127.3%)
-$24.28M(-33.0%)
Jun 1997
-
-$4.24M(-3.8%)
-$18.25M(-6.6%)
Mar 1997
-
-$4.08M(+35.6%)
-$17.12M(-15.4%)
Dec 1996
-$14.84M(-6.7%)
-$6.34M(-76.1%)
-$14.84M(-23.6%)
Sep 1996
-
-$3.60M(-16.1%)
-$12.00M(-17.6%)
Jun 1996
-
-$3.10M(-72.2%)
-$10.20M(+19.0%)
Mar 1996
-
-$1.80M(+48.6%)
-$12.60M(+9.4%)
Dec 1995
-$13.91M(-6.6%)
-$3.50M(-94.4%)
-$13.90M(+4.1%)
Sep 1995
-
-$1.80M(+67.3%)
-$14.50M(+10.5%)
Jun 1995
-
-$5.50M(-77.4%)
-$16.20M(-14.1%)
Mar 1995
-
-$3.10M(+24.4%)
-$14.20M(-8.4%)
Dec 1994
-$13.06M(-49.0%)
-$4.10M(-17.1%)
-$13.10M(-15.9%)
Sep 1994
-
-$3.50M(0.0%)
-$11.30M(-34.5%)
Jun 1994
-
-$3.50M(-75.0%)
-$8.40M(+28.2%)
Mar 1994
-
-$2.00M(+13.0%)
-$11.70M(-33.0%)
Dec 1993
-$8.76M(+27.4%)
-$2.30M(-283.3%)
-$8.80M(-23.9%)
Sep 1993
-
-$600.00K(+91.2%)
-$7.10M(+19.3%)
Jun 1993
-
-$6.80M(-855.6%)
-$8.80M(+3.3%)
Mar 1993
-
$900.00K(+250.0%)
-$9.10M(+24.8%)
Dec 1992
-$12.07M(+54.7%)
-$600.00K(+73.9%)
-$12.10M(+31.3%)
Sep 1992
-
-$2.30M(+67.6%)
-$17.60M(+26.4%)
Jun 1992
-
-$7.10M(-238.1%)
-$23.90M(-2.1%)
Mar 1992
-
-$2.10M(+65.6%)
-$23.40M(+12.0%)
Dec 1991
-$26.62M(-51.4%)
-$6.10M(+29.1%)
-$26.60M(+2.9%)
Sep 1991
-
-$8.60M(-30.3%)
-$27.40M(-20.2%)
Jun 1991
-
-$6.60M(-24.5%)
-$22.80M(-16.3%)
Mar 1991
-
-$5.30M(+23.2%)
-$19.60M(-11.4%)
Dec 1990
-$17.58M(+5.6%)
-$6.90M(-72.5%)
-$17.60M(-64.5%)
Sep 1990
-
-$4.00M(-17.6%)
-$10.70M(-59.7%)
Jun 1990
-
-$3.40M(-3.0%)
-$6.70M(-103.0%)
Mar 1990
-
-$3.30M
-$3.30M
Dec 1989
-$18.61M(-102.9%)
-
-
Dec 1988
-$9.18M(+35.6%)
-
-
Dec 1987
-$14.24M(+38.8%)
-
-
Dec 1986
-$23.27M(-525.7%)
-
-
Dec 1985
-$3.72M(-6.0%)
-
-
Dec 1984
-$3.51M(+63.3%)
-
-
Dec 1983
-$9.55M(>-9900.0%)
-
-
Dec 1982
$40.00K(+100.9%)
-
-
Dec 1981
-$4.32M(+51.2%)
-
-
Dec 1980
-$8.84M
-
-

FAQ

  • What is Bio-Rad Laboratories, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. annual cash from investing year-on-year change?
  • What is Bio-Rad Laboratories, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. quarterly cash from investing year-on-year change?
  • What is Bio-Rad Laboratories, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Bio-Rad Laboratories, Inc.?
  • What is Bio-Rad Laboratories, Inc. TTM cash from investing year-on-year change?

What is Bio-Rad Laboratories, Inc. annual cash from investing?

The current annual cash from investing of BIO is -$160.20M

What is the all-time high annual cash from investing for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high annual cash from investing is $20.21M

What is Bio-Rad Laboratories, Inc. annual cash from investing year-on-year change?

Over the past year, BIO annual cash from investing has changed by -$180.41M (-892.76%)

What is Bio-Rad Laboratories, Inc. quarterly cash from investing?

The current quarterly cash from investing of BIO is -$115.40M

What is the all-time high quarterly cash from investing for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high quarterly cash from investing is $179.99M

What is Bio-Rad Laboratories, Inc. quarterly cash from investing year-on-year change?

Over the past year, BIO quarterly cash from investing has changed by -$84.47M (-273.14%)

What is Bio-Rad Laboratories, Inc. TTM cash from investing?

The current TTM cash from investing of BIO is -$198.68M

What is the all-time high TTM cash from investing for Bio-Rad Laboratories, Inc.?

Bio-Rad Laboratories, Inc. all-time high TTM cash from investing is $71.00M

What is Bio-Rad Laboratories, Inc. TTM cash from investing year-on-year change?

Over the past year, BIO TTM cash from investing has changed by -$187.36M (-1654.66%)
On this page